Title:
嘔気嘔吐を治療するためのアミスルプリドと他の制吐薬との併用
Document Type and Number:
Japanese Patent JP6812360
Kind Code:
B2
Abstract:
A kit comprises at least one non-IV injectable unit dose of amisulpride and at least one dose of an acute-phase anti-emetic, for simultaneous, separate or sequential use in the treatment or prevention of chemotherapy- or radiotherapy-induced nausea and/or vomiting in a subject, wherein the subject is receiving or has received a chemotherapy or radiotherapy treatment regimen, and wherein the dosage regimen comprises the administration of the or each acute-phase anti-emetic on day 1, day 1 being the same day that a chemotherapy or radiotherapy is administered, and the administration of the, or at least one of the, non-IV injectable unit doses of amisulpride on day 2. Also provided is a kit comprising at least one non-IV injectable unit dose of amisulpride and at least one unit dose of IV amisulpride. Further provided is a non-IV injectable formulation of amisulpride, for use in the treatment or prevention of delayed-phase chemotherapy- or radiotherapy-induced nausea and/or vomiting in a subject.
More Like This:
Inventors:
Gilbert, Julian Clive
Robert William, Gristwood
Gabriel fox
Robert William, Gristwood
Gabriel fox
Application Number:
JP2017553076A
Publication Date:
January 13, 2021
Filing Date:
April 11, 2016
Export Citation:
Assignee:
ACACIA PHARMA LIMITED
International Classes:
A61K31/40; A61K31/4178; A61K31/5377; A61K31/56; A61K31/573; A61P1/08
Domestic Patent References:
| JP2013522181A | ||||
| JP2014526509A |
Other References:
武井大輔ら,日本緩和医療薬学雑誌,2009年 9月,Vol.2, No.4,pp.111-117.
Attorney, Agent or Firm:
Patent Business Corporation Moegi Patent Office